Infosys
INFY
10.55
0.00
0.00%
Infosys
US · INFY
#508 by market cap
Listed 1970
10.55
0.00
0.00%
Live - 5344 symbols - heartbeat 120s ago
· 2026-10-08 04:57
Pre-market
10.49
-0.57%
After-hours
10.53
-0.19%
Overnight
10.53
-0.19%
- Market cap
- 42.73B
- P/E (TTM)i
- 13.02
- P/Bi
- 4.44
- EPSi
- 0.80
- Div yieldi
- 4.97%
- 52W posi
- 1%
Reader sentiment
Are you bullish or bearish on INFY?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 7.47, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +4.57% YoY
Margins
- Gross margin
- 30.16%
- Operating margin
- 20.28%
- Net margin
- 16.44%
Key ratios & quality
- PEG ratioi
- 3.64
- Altman Z-Scorei
- 7.47
PEG uses trailing P/E against the 3-year net income growth rate (3.58%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 11.80B | 12.78B | 13.56B | 16.31B | 18.21B | 18.56B | 19.28B | 20.16B |
| Gross profit | 4.11B | 4.23B | 4.73B | 5.32B | 5.50B | 5.59B | 5.87B | 6.08B |
| Selling & admin expenses | 1.42B | 1.50B | 1.41B | 1.56B | 1.68B | 1.58B | 1.63B | 1.83B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 2.70B | 2.72B | 3.33B | 3.76B | 3.83B | 3.85B | 4.08B | 4.09B |
| Pretax profit | 3.00B | 3.10B | 3.60B | 4.04B | 4.13B | 4.35B | 4.45B | 4.51B |
| Tax | 803.00M | 757.00M | 973.00M | 1.07B | 1.14B | 1.18B | 1.29B | 1.19B |
| Net profit | 2.20B | 2.34B | 2.62B | 2.97B | 2.98B | 3.17B | 3.16B | 3.32B |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | 0.51 | 0.55 | 0.61 | 0.70 | 0.71 | 0.76 | 0.76 | 0.80 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 4.73B | 4.94B | 5.08B | 5.10B | 5.04B | 5.08B |
| Gross profit | 1.43B | 1.53B | 1.56B | 1.44B | 1.56B | 1.60B |
| Selling & admin expenses | 436.00M | 452.00M | 454.00M | 455.00M | 500.00M | 488.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 992.00M | 1.03B | 1.07B | 943.00M | 1.06B | 1.07B |
| Pretax profit | 1.12B | 1.14B | 1.17B | 1.04B | 1.17B | 1.16B |
| Tax | 303.00M | 329.00M | 325.00M | 287.00M | 248.00M | 343.00M |
| Net profit | 814.00M | 809.00M | 840.00M | 748.00M | 920.00M | 820.00M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.20 | 0.19 | 0.20 | 0.18 | 0.23 | 0.20 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 7.64B | 7.21B | 8.31B | 8.87B | 8.63B | 10.72B | 11.36B | 10.91B |
| Cash & ST investments | 3.79B | 3.11B | 3.75B | 3.22B | 2.35B | 3.35B | 4.38B | 3.75B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 12.25B | 12.26B | 14.83B | 15.56B | 15.31B | 16.52B | 17.42B | 16.45B |
| Total current liabilities | 2.69B | 2.76B | 3.26B | 4.43B | 4.77B | 4.65B | 5.01B | 5.52B |
| Short-term debt | -- | 82.00M | 101.00M | 115.00M | 151.00M | 235.00M | 287.00M | 333.00M |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 2,852,000,000.00 | 3,559,000,000.00 | 4,323,000,000.00 | 5,561,000,000.00 | 6,088,000,000.00 | 5,918,000,000.00 | 6,164,000,000.00 | 6,606,000,000.00 |
| Total equity | 9.40B | 8.70B | 10.50B | 9.99B | 9.22B | 10.61B | 11.26B | 9.84B |
| Retained earnings | 11.25B | 11.01B | 12.09B | 11.67B | 11.40B | 12.56B | 13.77B | 13.46B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 11.36B | 11.24B | 11.91B | 10.07B | 10.91B | 10.41B |
| Cash & ST investments | 4.38B | 4.09B | 5.02B | 3.05B | 3.75B | 3.17B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 17.42B | 17.45B | 18.06B | 15.95B | 16.45B | 16.36B |
| Total current liabilities | 5.01B | 5.15B | 5.22B | 5.56B | 5.52B | 5.59B |
| Short-term debt | 287.00M | 296.00M | 312.00M | 332.00M | 333.00M | 360.00M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 6,164,000,000.00 | 6,327,000,000.00 | 6,377,000,000.00 | 6,666,000,000.00 | 6,606,000,000.00 | 6,685,000,000.00 |
| Total equity | 11.26B | 11.12B | 11.69B | 9.29B | 9.84B | 9.67B |
| Retained earnings | 13.77B | 13.76B | 14.66B | 12.48B | 13.46B | 13.44B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 2.26B | 2.61B | 3.26B | 3.35B | 2.85B | 3.15B | 4.35B | 4.04B |
| Depreciation & amortization | 287.00M | 407.00M | 441.00M | 466.00M | 524.00M | 565.00M | 569.00M | 552.00M |
| Free cash flow | 1.91B | 2.15B | 2.97B | 3.06B | 2.53B | 2.88B | 4.09B | 3.73B |
| Dividends paid | -1.96B | -1.36B | -1.23B | -1.70B | -1.70B | -1.78B | -2.42B | -2.13B |
| Stock buybacks / issuance | -118.00M | -1.07B | 0 | -1.50B | -1.40B | 0 | 0 | -2.01B |
| Ending cash balance | 2.83B | 2.47B | 3.38B | 2.31B | 1.48B | 1.77B | 2.86B | 2.34B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 976.00M | 983.00M | 1.16B | 962.00M | 937.00M | 1.04B |
| Depreciation & amortization | 150.00M | 133.00M | 135.00M | 130.00M | 154.00M | 131.00M |
| Free cash flow | 892.00M | 884.00M | 1.10B | 915.00M | 833.00M | 955.00M |
| Dividends paid | 0 | -1.06B | -1.00M | -1.07B | 0 | -1.07B |
| Stock buybacks / issuance | 0 | -- | -- | -- | -1.00M | -- |
| Ending cash balance | 2.86B | 3.20B | 3.59B | 2.22B | 2.34B | 2.29B |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 22.73 | 25.85 | 27.38 | 29.07 | 31.19 | 32.10 | 29.02 | 31.57 |
| ROA %i | 17.95 | 19.02 | 19.29 | 19.51 | 19.32 | 19.90 | 18.61 | 19.57 |
| ROIC %i | 20.51 | 22.32 | 24.22 | 25.83 | 27.28 | 26.24 | 24.84 | 26.96 |
| 5-year avg ROE %i | 23.02 | 23.37 | 24.31 | 25.83 | 27.24 | 29.12 | 29.75 | 30.59 |
| EBIT margin %i | 23.15 | 24.41 | 26.71 | 24.91 | 22.84 | 23.72 | 23.32 | 22.59 |
| FCF / sales %i | 16.21 | 16.79 | 21.92 | 18.73 | 13.91 | 15.53 | 21.21 | 18.52 |
| Current ratioi | 2.84 | 2.62 | 2.55 | 2.00 | 1.81 | 2.31 | 2.27 | 1.98 |
| Quick ratioi | 2.66 | 2.47 | 2.39 | 1.83 | 1.64 | 2.12 | 2.09 | 1.80 |
| Debt / assetsi | 0.00 | 4.99 | 4.91 | 4.64 | 6.60 | 6.06 | 5.52 | 5.88 |
| LT debt / equityi | -- | 6.13 | 6.00 | 6.11 | 9.37 | 7.26 | 6.02 | 6.48 |
| Interest coveragei | -- | 129.96 | 139.31 | 150.48 | 118.86 | 78.61 | 91.76 | 96.87 |
| Revenue CAGR (3Y) %i | 7.49 | 7.78 | 7.42 | 11.40 | 12.53 | 11.03 | 5.73 | 3.44 |
| Net income CAGR (3Y) %i | 2.33 | 2.89 | 1.67 | 10.45 | 8.54 | 6.62 | 2.15 | 3.58 |
| FCF CAGR (3Y) %i | 9.70 | 8.33 | 15.15 | 16.89 | 5.70 | -1.03 | 10.20 | 13.78 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 29.02 | 30.48 | 29.12 | 32.81 | 31.57 | 32.12 |
| ROA %i | 18.61 | 18.46 | 18.66 | 19.89 | 19.57 | 19.66 |
| ROIC %i | 24.84 | 25.90 | 24.78 | 27.67 | 26.96 | 27.62 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 23.32 | 23.33 | 23.42 | 22.68 | 22.59 | 22.56 |
| FCF / sales %i | 21.21 | 19.88 | 21.03 | 19.11 | 18.52 | 18.74 |
| Current ratioi | 2.27 | 2.18 | 2.28 | 1.81 | 1.98 | 1.86 |
| Quick ratioi | 2.09 | 2.00 | 2.11 | 1.64 | 1.80 | 1.67 |
| Debt / assetsi | 5.52 | 5.67 | 5.46 | 6.13 | 5.88 | 5.64 |
| LT debt / equityi | 6.02 | 6.26 | 5.79 | 7.00 | 6.48 | 5.85 |
| Interest coveragei | 91.76 | 94.81 | 98.11 | 97.87 | 96.87 | 95.40 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Financial services is the largest reported line at 27.92% of revenue, across 8 reported segments.
- No single line clears half of revenue; Manufacturing is next at 15.92%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Financial services27.92%
Manufacturing15.92%
Energy, Utilities, Resources and Services13.38%
Retail12.81%
Communication12.00%
Life sciences7.97%
Hi-Tech7.69%
All other segments2.30%
Quote time 2026-10-08 04:57:21 · For reference only, not investment advice and not tailored to your situation.